These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11515200)

  • 21. Use of the rabbit with a failing heart to test for torsadogenicity.
    Hamlin RL; Kijtawornrat A
    Pharmacol Ther; 2008 Aug; 119(2):179-85. PubMed ID: 18691764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic methadone therapy complicated by torsades de pointes: a case report.
    Pimentel L; Mayo D
    J Emerg Med; 2008 Apr; 34(3):287-90. PubMed ID: 18022786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long QT-syndrome as a drug-induced side effect].
    Pohjola-Sintonen S
    Duodecim; 1998; 114(19):1891, 1893, 1895. PubMed ID: 11717743
    [No Abstract]   [Full Text] [Related]  

  • 24. [Why is QT interval interesting?].
    Elming H; Sonne J; Lublin HK
    Ugeskr Laeger; 2002 Feb; 164(6):750-4. PubMed ID: 11851179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Foreign report on side effects of drugs].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1991 Nov; 135(45):2120-2. PubMed ID: 1944688
    [No Abstract]   [Full Text] [Related]  

  • 26. Hands-on help Torsades de pointes.
    Dulak SB
    RN; 2004 Oct; 67(10):24ac1-4. PubMed ID: 15552376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a non-human primate model of drug-induced torsades de pointes.
    Beatch GN; Davis DR; Dickenson DR; Adaikan PG; Hayes E; Rhamberg M; Walker MJ
    Proc West Pharmacol Soc; 1997; 40():13-6. PubMed ID: 9436200
    [No Abstract]   [Full Text] [Related]  

  • 28. Torsades de Pointes in Coronavirus Disease 2019 Infection.
    Lalabekyan B; Kunst G; Skelton VA
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):954-955. PubMed ID: 32753328
    [No Abstract]   [Full Text] [Related]  

  • 29. Perception of validity of clinical and preclinical methods for assessment of torsades de pointes liability.
    Pugsley MK; Hancox JC; Curtis MJ
    Pharmacol Ther; 2008 Aug; 119(2):115-7. PubMed ID: 18590766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced prolongation of the QT interval.
    Viskin S; Justo D; Zeltser D
    N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208785
    [No Abstract]   [Full Text] [Related]  

  • 31. Torsade de Pointes--a cardiac ballet.
    Lessig ML; DeAngelis R
    Crit Care Nurse; 1991; 11(10):63-7. PubMed ID: 1954750
    [No Abstract]   [Full Text] [Related]  

  • 32. Methadone-induced torsade de pointes in a patient with normal baseline QT interval.
    Almehmi A; Malas AM; Yousufuddin M; Rosencrance JG
    W V Med J; 2004; 100(4):147-8. PubMed ID: 15471174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Torsades de pointes].
    Kishi F; Nomura M; Saito K; Ito S; Nakaya Y
    Ryoikibetsu Shokogun Shirizu; 1996; (12):391-4. PubMed ID: 9047493
    [No Abstract]   [Full Text] [Related]  

  • 34. A farewell to QT dispersion. Are the alternatives any better?
    Rautaharju PM
    J Electrocardiol; 2005 Jan; 38(1):7-9. PubMed ID: 15660341
    [No Abstract]   [Full Text] [Related]  

  • 35. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Torsades de pointes--a rare (?) and unpredictable arrhythmia].
    Edvardsson N; Houltz B; Swedberg K
    Lakartidningen; 1993 Dec; 90(50):4540. PubMed ID: 8264288
    [No Abstract]   [Full Text] [Related]  

  • 37. Early afterdepolarizations, U waves, and torsades de pointes.
    Wu J; Wu J; Zipes DP
    Circulation; 2002 Feb; 105(6):675-6. PubMed ID: 11839619
    [No Abstract]   [Full Text] [Related]  

  • 38. Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes.
    Bar-Meir E; Schein O; Eisenkraft A; Rubinshtein R; Grubstein A; Militianu A; Glikson M;
    Crit Rev Toxicol; 2007 Mar; 37(3):279-85. PubMed ID: 17453935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Not just slow: double trouble.
    Indik JH
    Am J Med; 2008 Jan; 121(1):19-20. PubMed ID: 18187068
    [No Abstract]   [Full Text] [Related]  

  • 40. Self-Terminating Ventricular Fibrillation in Vandetanib-Induced Torsades de Pointes.
    Loffi M; Toffetti L; Gianni C; Lombardi F
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):811-3. PubMed ID: 25648339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.